Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-06-15

FDA Approved: EFAVIRENZ — Original Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved the original application for efavirenz from Cipla USA Inc. as a generic version for HIV-1 infection. This marks another entry in approved generic a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EFAVIRENZ (efavirenz)

Snippet

ORIG AP for EFAVIRENZ (EFAVIRENZ)